Semler Scientific, Inc., headquartered in Santa Clara, California, offers technology and software solutions to enhance healthcare clinical effectiveness, focusing on chronic diseases with products like QuantaFlo for PAD diagnosis. The company, which employs 127 people and went public in 2014, also distributes Insulin Insights in the U.S. for managing Type 2 diabetes.
SMLR has been in the news recently: Semler Scientific, Inc. recently purchased 581 bitcoins for $40 million as its primary treasury reserve asset, resulting in a 30% increase in its stock shares. This move follows in the footsteps of MicroStrategy and has caused some analysts to question the company's growth potential amid increased competition.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.